Molecules/BELATACEPT

BELATACEPT

Molecular Identity

ProteinApprovedFirst approved 2011

Mechanism of action: T-lymphocyte activation antigen CD86 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BELATACEPTBMS-224818LEA29YNujolixNULOJIX

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BELATACEPT

Loading drug network...